Cargando…

Prevalence of risk factors for platelet transfusion refractoriness in multitransfused hemato-oncological patients at tertiary care center in North India

BACKGROUND: This study was designed to determine the prevalence and assess the risk factors responsible for platelet transfusion refractoriness in hemato-oncological patients. MATERIALS AND METHODS: The study included 30 patients. Twelve were clinically diagnosed as aplastic anemia and the 18 were o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumawat, Vijay, Sharma, Ratti Ram, Malhotra, Pankaj, Marwaha, Neelam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339935/ https://www.ncbi.nlm.nih.gov/pubmed/25722575 http://dx.doi.org/10.4103/0973-6247.150953

Ejemplares similares

Platelet Septic Transfusion Reactions in Patients With Hemato-Oncological Diseases
por: Razjou, Farhad, et al.
Publicado: (2017)

Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients
por: Dhawan, Hari Krishan, et al.
Publicado: (2014)

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)

Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
por: van Osch, Thijs L. J., et al.
Publicado: (2022)

Prevalence of transfusion-transmitted Chagas disease among multitransfused patients in Brazil
por: De Paula, Erich V, et al.
Publicado: (2008)

Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort
por: Bhattacharya, Prasun, et al.
Publicado: (2011)

Anti-N antibody reacting at 37°C: An unusual occurrence interfering with routine testing: Two interesting cases
por: Kumawat, Vijay, et al.
Publicado: (2015)

Use of “smartphone” technology for managing workload in transfusion-transmissible infection (nucleic acid testing) laboratory for platelet concentrate inventory management resulting in timely issue of platelets: Experience from a tertiary care center
por: Hans, Rekha, et al.
Publicado: (2017)

Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion
por: Jain, Ashish, et al.
Publicado: (2018)

Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India
por: Hans, Rekha, et al.
Publicado: (2019)

Direct antiglobulin test positivity in multi-transfused thalassemics
por: Jain, Ashish, et al.
Publicado: (2016)

Stem Cells in Hemato-Oncology
por: Damodar, S
Publicado: (2006)

Prospective study estimating healthcare associated infections in a paediatric hemato-oncology unit of a tertiary care hospital in north India
por: Gupta, Ayush, et al.
Publicado: (2013)

Transfusion medicine in India: Expanding horizons
por: Marwaha, Neelam
Publicado: (2014)

Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods
por: Singh, Ravindra P., et al.
Publicado: (2009)

Haematological profile of patients with mixed-phenotype acute leukaemia from a tertiary care centre of north India
por: Sharma, Manupriya, et al.
Publicado: (2017)

Role of plasma exchange in postpartum microangiopathies: An experience from a tertiary care center
por: Hans, Rekha, et al.
Publicado: (2019)

An incident of incorrect blood component transfusion: The need for constant hemovigilance
por: Malhotra, Sheetal, et al.
Publicado: (2015)

Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods
por: Kaur, Daljit, et al.
Publicado: (2015)

Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors
por: Hans, Rekha, et al.
Publicado: (2019)

Serial assessment of biochemical parameters of red cell preparations to evaluate safety for neonatal transfusions
por: Mukherjee, Somnath, et al.
Publicado: (2010)

PRES in the course of hemato-oncological treatment in children
por: Musioł, Katarzyna, et al.
Publicado: (2017)

Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients
por: Caldwell, Louise, et al.
Publicado: (2022)

Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components
por: Singh, Lakhvinder, et al.
Publicado: (2023)

Alloimmunization in multitransfused liver disease patients: Impact of underlying disease
por: Bajpai, Meenu, et al.
Publicado: (2016)

The Impact of Clinical Pharmacy Services in a Tertiary Care Center Specialized in Pediatric Hemato-Oncology
por: Gradwohl, Christina, et al.
Publicado: (2022)

Transfusion related complications in hemophilia
por: Marwaha, Neelam
Publicado: (2013)

Palestinian Children in the Hemato-Oncology Ward of an Israeli Hospital
por: Nehari, Miri, et al.
Publicado: (2008)

Monitoring of the Environment at the Transplant Unit—Hemato-Oncology Clinic
por: Matoušková, Ivanka, et al.
Publicado: (2014)

Hemato-oncology Tourism in Israel: A Retrospective Review
por: Hod, Keren, et al.
Publicado: (2020)

COVID-19 in Omani Children with Hemato-Oncology Diseases
por: Al Yazidi, Laila S, et al.
Publicado: (2020)

Analysis of Vancomycin-Resistant Enterococci in Hemato-Oncological Patients
por: Hricová, Kristýna, et al.
Publicado: (2020)

Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
por: Zhang, Jing-Cheng, et al.
Publicado: (2023)

Evaluation and management of platelet transfusion refractoriness
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

Analysis of adverse events and predisposing factors in voluntary and replacement whole blood donors: A study from north India
por: Agnihotri, Naveen, et al.
Publicado: (2012)

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies.
por: Lee, M., et al.
Publicado: (1988)

Catheter-related bloodstream infections in hemato-oncology paediatric patients
por: Giamberardino, HIG, et al.
Publicado: (2015)

Pediatric Hemato-Oncology Care Amid the COVID-19 Pandemic
por: Sahi, Puneet Kaur, et al.
Publicado: (2021)

Remdesivir Reduces Mortality in Hemato-Oncology Patients with COVID-19
por: Aksak-Wąs, Bogusz Jan, et al.
Publicado: (2022)

Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1dfrgv2brev5q9trpp1nd6pc7u